Health Care Innovation Challenge
by:
Iola BonggayThe Centers for Medicare and & Medicaid Services, more commonly referred to as CMS, is a federal government agency operating within the United States Department of Health and Human Services that is primarily accountable for administering medicare programs and collaborate with state governments to administer medicaid services.
The grants and initiatives of the CMS are all geared towards the achievement of its primary agency mission which is to ensure health care security to all its beneficiaries.
In keeping with this mission, the Centers for Medicare and & Medicaid Services has recently established the Health Care Innovation Challenge in an attempt to solicit proposals to establish interesting new models of service delivery that can potentially deliver the three-part aim of better health, better health care, and finally, lower costs through the improved quality of Medicare, Medicaid, and Children's Health Insurance Program.
The projects that will be funded under this program should be able to pave the way towards the achievement of the following objectives:
(continued...)
Health Care Innovation Challenge
Page 2
About The Author
Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs.
She also maintains Websites providing resources on environmental grants and grants for youth programs.
|
Additional Resources
category - Health Grants
Improving Health of People with Intellectual Disabilities ProgramIn keeping with this mission, the Centers for Disease Control and Prevention has constituted the Improving Health of People with Intellectual Disabilities Program in an attempt to financially support initiatives for people suffering from intellectual disabilities, thereby seeking to increase healthy behaviors and improve access to appropriate health services.
Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability ProgramIn this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.
Strategic Alliances for Medications Development to Treat Substance Use Disorder ProgramThe National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.
Exploratory Clinical Trials for Small Business Grant ProgramThe National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) in order to establish the Exploratory Clinical Trials for Small Business Grant Program wherein they aim to establish a vehicle for Small Business Concerns (SBCs) in the process of submitting Small Business Technology Transfer (STTR) grant applications for exploratory clinical trials directly to the NIND